Cargando…
Fr492 SIGNIFICANTLY REDUCED MORTALITY IN COVID-19 PATIENTS WITH GASTROINTESTINAL MANIFESTATIONS
Autores principales: | Livanos, Alexandra E., Cossarini, Francesca, Parigi, Tommaso, Dunleavy, Katie A., Dixon, Rebekah E., Jha, Divya, Tokuyama, Minami, Chen, Steven T., Colombel, Jean Frederic, Merad, Miriam, Gnjatic, Sacha, Danese, Silvio, Aghemo, Alessio, Kumta, Nikhil A., Petralia, Francesca, Mehandru, Saurabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108231/ http://dx.doi.org/10.1016/S0016-5085(21)01513-4 |
Ejemplares similares
-
Fr137 FIRST HIGH DIMENSIONAL EXAMINATION OF INTESTINAL BIOPSIES IN PATIENTS WITH COVID-19
por: Jha, Divya, et al.
Publicado: (2021) -
1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION
por: Meringer, Hadar, et al.
Publicado: (2022) -
785 SARS-COV-2 INFECTS ENTEROCYTES IN VIVO AND CAN PERSIST UP TO 7 MONTHS FOLLOWING RESOLUTION OF SYMPTOMS
por: Tokuyama, Minami, et al.
Publicado: (2021) -
Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021) -
Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)